All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Teva Pharmaceutical Industries Limited revenue reports

Teva Pharmaceutical Industries Limited financial reports, Teva Pharmaceutical Industries Limited annual revenue in 2024. When does Teva Pharmaceutical Industries Limited report revenue?
Add to widgets
Added to widgets

Teva Pharmaceutical Industries Limited total revenue, net income and dynamics of changes in US dollar today

Net revenue of Teva Pharmaceutical Industries Limited on 31/12/2019 amounted to 4 468 000 000 $. Net income Teva Pharmaceutical Industries Limited - 110 000 000 $. Information about net income is used from open sources. Net income, revenue and dynamics - the main financial indicators of Teva Pharmaceutical Industries Limited. Chart of online financial report of Teva Pharmaceutical Industries Limited. The financial graph of Teva Pharmaceutical Industries Limited shows the values and changes of such indicators: total assets, net income, net revenue. The financial report on the chart of Teva Pharmaceutical Industries Limited allows you to clearly see the dynamics of fixed assets.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2019 4 468 000 000 $ -1.996 % ↓ 110 000 000 $ -
30/09/2019 4 264 000 000 $ -5.851 % ↓ -314 000 000 $ -
30/06/2019 4 337 000 000 $ -7.743 % ↓ -689 000 000 $ -
31/03/2019 4 295 000 000 $ - -105 000 000 $ -
31/12/2018 4 559 000 000 $ - -2 886 000 000 $ -
30/09/2018 4 529 000 000 $ - -208 000 000 $ -
30/06/2018 4 701 000 000 $ - -176 000 000 $ -
Show:
to

Teva Pharmaceutical Industries Limited financial report charts

Dates of Teva Pharmaceutical Industries Limited finance reports: 30/06/2018, 30/09/2019, 31/12/2019. The dates of financial statements are strictly regulated by law and financial statements. The latest financial report of Teva Pharmaceutical Industries Limited is available online for such a date - 31/12/2019. Gross profit Teva Pharmaceutical Industries Limited is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Teva Pharmaceutical Industries Limited is 1 958 000 000 $

Teva Pharmaceutical Industries Limited quarterly report dates

Cost of revenue Teva Pharmaceutical Industries Limited is the total cost of producing and distributing of products and services of a company. Cost of revenue Teva Pharmaceutical Industries Limited is 2 510 000 000 $ Total revenue Teva Pharmaceutical Industries Limited refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Teva Pharmaceutical Industries Limited is 4 468 000 000 $ Operating income Teva Pharmaceutical Industries Limited is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Teva Pharmaceutical Industries Limited is 708 000 000 $

Net income Teva Pharmaceutical Industries Limited is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Teva Pharmaceutical Industries Limited is 110 000 000 $ Current assets Teva Pharmaceutical Industries Limited is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Teva Pharmaceutical Industries Limited is 13 576 000 000 $ Total assets Teva Pharmaceutical Industries Limited refers to the total amount of assets owned by a person or entity. Total assets Teva Pharmaceutical Industries Limited is 57 582 000 000 $

31/12/2019 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
1 958 000 000 $ 1 829 000 000 $ 1 894 000 000 $ 1 855 000 000 $ 1 866 000 000 $ 2 021 000 000 $ 2 061 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
2 510 000 000 $ 2 435 000 000 $ 2 443 000 000 $ 2 440 000 000 $ 2 693 000 000 $ 2 508 000 000 $ 2 640 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
4 468 000 000 $ 4 264 000 000 $ 4 337 000 000 $ 4 295 000 000 $ 4 559 000 000 $ 4 529 000 000 $ 4 701 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
708 000 000 $ 697 000 000 $ 679 000 000 $ 642 000 000 $ 654 000 000 $ 644 000 000 $ 744 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
110 000 000 $ -314 000 000 $ -689 000 000 $ -105 000 000 $ -2 886 000 000 $ -208 000 000 $ -176 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
232 000 000 $ 240 000 000 $ 276 000 000 $ 261 000 000 $ 295 000 000 $ 311 000 000 $ 290 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
3 760 000 000 $ 3 567 000 000 $ 3 658 000 000 $ 3 653 000 000 $ 3 905 000 000 $ 3 885 000 000 $ 3 957 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
13 576 000 000 $ 12 542 000 000 $ 13 805 000 000 $ 13 432 000 000 $ 13 794 000 000 $ 13 881 000 000 $ 14 711 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
57 582 000 000 $ 57 246 000 000 $ 59 424 000 000 $ 59 854 000 000 $ 60 683 000 000 $ 65 061 000 000 $ 67 030 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
1 975 000 000 $ 1 241 000 000 $ 2 165 000 000 $ 1 973 000 000 $ 1 782 000 000 $ 1 875 000 000 $ 1 861 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
13 786 000 000 $ 14 107 000 000 $ 14 452 000 000 $ 14 028 000 000 $ 14 322 000 000 $ 14 830 000 000 $ 14 215 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
42 519 000 000 $ 42 322 000 000 $ 44 174 000 000 $ 44 033 000 000 $ 44 889 000 000 $ 45 927 000 000 $ 47 662 000 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
73.84 % 73.93 % 74.34 % 73.57 % 73.97 % 70.59 % 71.11 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
13 972 000 000 $ 13 790 000 000 $ 14 122 000 000 $ 14 732 000 000 $ 14 707 000 000 $ 13 905 000 000 $ 14 178 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
538 000 000 $ 325 000 000 $ -227 000 000 $ 112 000 000 $ 367 000 000 $ 421 000 000 $ 162 000 000 $

Last revenue report of Teva Pharmaceutical Industries Limited was 31/12/2019. According to last financial report total revenue in Teva Pharmaceutical Industries Limited was 4 468 000 000 US dollar and changed by -1.996% since last year. Net income in Teva Pharmaceutical Industries Limited was 110 000 000 $ in last quartal, net income changes to 0%.

Current cash Teva Pharmaceutical Industries Limited - the sum of all of the cash a company has on the date of report. Current cash Teva Pharmaceutical Industries Limited is 1 975 000 000 $ Current debt Teva Pharmaceutical Industries Limited is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Teva Pharmaceutical Industries Limited is 13 786 000 000 $ Total debt Teva Pharmaceutical Industries Limited is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year. Total debt Teva Pharmaceutical Industries Limited is 42 519 000 000 $

Teva Pharmaceutical Industries Limited stocks data

Teva Pharmaceutical Industries Limited financials